Safety of the progesterone-releasing vaginal ring (PVR) among lactating women: A systematic review
- PMID: 25869631
- DOI: 10.1016/j.contraception.2015.04.001
Safety of the progesterone-releasing vaginal ring (PVR) among lactating women: A systematic review
Abstract
Context: Lactation causes a delay in ovulation in the postpartum period, and therefore a delay in the resumption of menses. However, return to fertility is variable in the postpartum period and is contingent upon numerous factors. The postpartum period is therefore a critical time to initiate effective contraception in order to support the numerous beneficial health outcomes of optimal pregnancy spacing. Breastfeeding women have an unmet need for highly effective birth control methods that do not interfere with lactation and that are safe for their infants. The progesterone-releasing vaginal ring (PVR) releases a natural progesterone that suppresses ovulation and is specifically designed for breastfeeding women in the first postpartum year.
Objective: To review the published peer-reviewed literature regarding the safety and effectiveness of the PVR used for contraception among lactating women, as well as the safety for their infants. Results of this review informed the decisions of the Guideline Development Group to include recommendations on contraceptive eligibility for the PVR within the World Health Organization Medical Eligibility Criteria for Contraceptive Use, 5th Edition.
Methods: We searched the PubMed, Popline, and LILACS bibliographic databases for articles published in any language from database inception through October 1, 2014. We reviewed the literature for evidence regarding the safety of the PVR among breastfeeding women using the method, as well as for their infants. The US Preventive Services Task Force system was applied to assess the quality of the evidence.
Results: Seven articles met our criteria for inclusion in this review. All studies were of a prospective cohort design. All studies consistently showed that use of the PVR among breastfeeding women compares favorably to other methods of contraception with regard to effectiveness, does not compromise a woman's breastfeeding performance, and does not adversely affect infant growth during the first year postpartum.
Conclusion: The PVR is a safe and highly effective method of contraception for use among breastfeeding women. It should be offered to women who plan to breastfeed in the context of postpartum contraceptive counseling.
Keywords: Breastfeeding; Contraception; Lactation; Progesterone vaginal ring.
Copyright © 2016. Published by Elsevier Inc.
Similar articles
-
Contraceptives for lactating women: a comparative trial of a progesterone-releasing vaginal ring and the copper T 380A IUD.Contraception. 1997 Apr;55(4):225-32. doi: 10.1016/s0010-7824(97)00008-5. Contraception. 1997. PMID: 9179454 Clinical Trial.
-
The comparative trial of TCu 380A IUD and progesterone-releasing vaginal ring used by lactating women.Contraception. 1998 Jun;57(6):371-9. doi: 10.1016/s0010-7824(98)00043-2. Contraception. 1998. PMID: 9693396 Clinical Trial.
-
New IPPF statement on breastfeeding, fertility and post-partum contraception.IPPF Med Bull. 1990 Apr;24(2):2-4. IPPF Med Bull. 1990. PMID: 12316285
-
The effect of lactation on ovulation and fertility.Clin Perinatol. 1987 Mar;14(1):39-50. Clin Perinatol. 1987. PMID: 3549114 Review.
-
Progesterone vaginal ring for contraceptive use during lactation.Contraception. 2010 Nov;82(5):428-34. doi: 10.1016/j.contraception.2010.05.016. Contraception. 2010. PMID: 20933116 Review.
Cited by
-
An overview of reviews of breastfeeding barriers and facilitators: Analyzing global research trends and hotspots.Glob Epidemiol. 2025 Mar 6;9:100192. doi: 10.1016/j.gloepi.2025.100192. eCollection 2025 Jun. Glob Epidemiol. 2025. PMID: 40129756 Free PMC article. Review.
-
A randomised trial of a contraceptive vaginal ring in women at risk of HIV infection in Rwanda: Safety of intermittent and continuous use.PLoS One. 2018 Jun 1;13(6):e0197572. doi: 10.1371/journal.pone.0197572. eCollection 2018. PLoS One. 2018. PMID: 29856848 Free PMC article. Clinical Trial.
-
Measuring potential interest in a postpartum contraceptive vaginal ring among breastfeeding women in India.PLOS Glob Public Health. 2022 Jul 27;2(7):e0000804. doi: 10.1371/journal.pgph.0000804. eCollection 2022. PLOS Glob Public Health. 2022. PMID: 36962466 Free PMC article.
-
Pharmacokinetics and tolerability of a novel progesterone intravaginal ring in sheep.Drug Deliv Transl Res. 2019 Oct;9(5):1008-1016. doi: 10.1007/s13346-019-00646-x. Drug Deliv Transl Res. 2019. PMID: 31066007
-
High acceptability of a contraceptive vaginal ring among women in Kigali, Rwanda.PLoS One. 2018 Jun 18;13(6):e0199096. doi: 10.1371/journal.pone.0199096. eCollection 2018. PLoS One. 2018. PMID: 29912906 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous